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Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder 
characterized by its significant social impact and high heritability. The latest meta-analysis 
of ASD GWAS (genome-wide association studies) has revealed the association of several 
SNPs that were replicated in additional sets of independent samples. However, summary 
statistics from GWAS can be used to perform a gene-based analysis (GBA). GBA allows 
to combine all genetic information across the gene to create a single statistic (p-value 
for each gene). Thus, PASCAL (Pathway scoring algorithm), a novel GBA tool, has been 
applied to the summary statistics from the latest meta-analysis of ASD. GBA approach 
(testing the gene as a unit) provides an advantage to perform an accurate insight into 
the biological ASD mechanisms. Therefore, a gene-network analysis and an enrichment 
analysis for KEGG and GO terms were carried out. GENE2FUNC was used to create gene 
expression heatmaps and to carry out differential expression analysis (DEA) across GTEx 
v7 tissues and Brainspan data. dbMDEGA was employed to perform a DEG analysis 
between ASD and brain control samples for the associated genes and interactors.
Results: PASCAL has identified the following loci associated with ASD: XRN2, NKX2-4, 
PLK1S1, KCNN2, NKX2-2, CRHR1-IT1, C8orf74 and LOC644172. While some of these 
genes were previously reported by MAGMA (XRN2, PLK1S1, and KCNN2), PASCAL has 
been useful to highlight additional genes. The biological characterization of the ASD-
associated genes and their interactors have demonstrated the association of several GO 
and KEGG terms. Moreover, DEA analysis has revealed several up- and down-regulated 
clusters. In addition, many of the ASD-associated genes and their interactors have shown 
association with ASD expression datasets.
Conclusions: This study identifies several associations at a gene level in ASD. Most of 
them were previously reported by MAGMA. This fact proves that PASCAL is an efficient 
GBA tool to extract additional information from previous GWAS. In addition, this study 
has characterized for the first time the biological role of the ASD-associated genes across 
brain regions, neurodevelopmental stages, and ASD gene-expression datasets.
Keywords: autism spectrum disorder, gene-based analysis, neurodevelopmental disorders, differential expression 
analysis, gene-network analysis, genome-wide association study, single-nucleotide polymorphism
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INTRODUCTION
Autism spectrum disorder (ASD) is a neurodevelopmental 
disorder (NDD) characterized by impaired social interaction 
and communication together with repetitive and restrictive 
behaviors (American Psychiatric Association, 2013). The 
estimated prevalence of ASD stands at approximately 1% in the 
general population, and this value is influenced by whether adult 
or child and adolescent populations are considered (The National 
Academies of Sciences, 2015).
ASD is a multifactorial disorder, meaning that several factors 
(both environmental and genetic) are involved in the development 
of this condition. Thus, rare genetic variation, including small 
deletions and duplications (indels), CNVs (copy number variation) 
and SNVs (single-nucleotide variation) contribute significantly to 
ASD liability. In addition, the pattern of inheritance (common or 
rare) and the origin of these mutations (inherited or de novo) will 
also differentially contribute to the genetic risk. Thus, rare inherited 
variation (MAF < 1%) alone only explains 3% of ASD genetic risk 
(Sanders et al., 2015). However, common variation accounts for a 
substantial fraction of ASD heritability (50%) (Cross-Disorder 
Group of the Psychiatric Genomics Consortium, 2013; Smoller 
et al., 2013; Glessner et al., 2014; Anttila et al., 2018). Early GWAS 
of ASD have failed to detect strong signals which could possibly be 
due to the presence of phenotypic heterogeneity across collections 
and the need of much larger sample sizes to achieve an adequate 
statistical power (Weiss et al., 2009; Anney et al., 2010; Ma et al., 
2010). Different associated signals were considered as plausible risk 
variants for years even when subsequent studies did not replicate 
most of them. Thus, some examples of associated SNPs (single-
nucleotide polymorphisms) are the following: rs10513025 (SEMA5A), 
rs4141463 (MACROD2), and rs4307059 (MSNP1), among others 
(Weiss et al., 2009; Kerin et al., 2012; Jones et al., 2013; Torrico et al., 
2017). However, the genetic landscape of ASD has evolved over the 
past 10 years, and the latest ASD GWAS meta-analysis conducted by 
the Psychiatric Genomic Consortium (PGC) is a proof of that. PGC 
has made an incredible effort not only to increase sample size up to 
10,000 cases and controls but also to develop well-defined quality 
control and imputation pipelines. The latest ASD GWAS meta-
analysis has led to the identification of 93 genome-wide significant 
markers of which only 53 were replicated in independent cohorts. 
Top associated SNPs were rs910805 (chromosome 20; p-value: 
2.04 × 10−9) and rs10099100 (chromosome 8; p-value: 1.07 × 10−8), 
among others (Grove et  al., 2019). However, GWAS information can 
be also analyzed following a gene-based analysis (GBA) approach. 
Thus, p-values for each SNP within a gene are combined to obtain 
a single statistic for each single gene across the genome (Huang 
et al., 2011). GBA strategies employ summary statistics from GWAS 
without the need of individual genotypes. The study of genes as 
testing units with a biological entity provides the correct framework 
to carry out secondary approaches. These additional studies help to 
characterize the molecular and cellular mechanisms involved in the 
pathogenesis of the disease (Wang et al., 2007).
MAGMA is one of the most commonly used GBA methods 
together with VEGAS. (de Leeuw et al., 2015; Liu et al., 2010). Thus, 
the latest ASD GWAS meta-analysis includes an additional GBA 
done by MAGMA. The top associated genes reported in this study 
were KIZ and XRN2 (chromosome 20), MFHAS1, XKR6, MSRA, 
and SOX7 (chromosome 8). The remaining associated genes were 
KCNN2, KANSL1, MACROD2, WNT3, MAPT, CRHR1, NTM, 
MMP12, and BLK (Grove et al., 2019).
PASCAL (Pathway scoring algorithm) is one of the most recent 
GBA approaches. PASCAL generates gene scores by aggregating 
SNP p-values from GWAS meta-analysis while correcting for LD 
(linkage disequilibrium) using 1000 Genomes data. Thus, PASCAL 
creates a pairwise SNP by SNP correlation matrix. MAGMA also 
allows to correct by LD structure but in a different way. It creates 
a SNP matrix (principal components) pruning away those SNPs 
presenting small eigenvalues in the matrix (de Leeuw et al., 2015; 
Lamparter et al., 2016). Moreover, PASCAL is distinguishable 
from VEGAS and MAGMA by having more statistical power and 
by being computationally less demanding (Lamparter et al., 2016).
The main aim of this paper is to further mine the summary 
data from the meta-analysis of ASD by PASCAL. Although it 
is expected that the results do not vary much from those genes 
found by MAGMA, additional analysis will be performed to 
characterize the functional role of the ASD-associated genes. 
Therefore, gene-network analysis, enrichment analysis, and meta-
analysis of DEG (different expressed genes) in ASD brain will be 
carried out to gain information about their biological function.
METHODS
GWAS Meta-Analysis
Summary statistics from the latest ASD GWAS meta-analysis 
were obtained from the public repository available in the PGC 
website (http://www.med.unc.edu/pgc/results-and-downloads). 
The following data set was employed: iPSYCH_PGC_ASD_
Nov2017.gz (Grove et al., 2019) which includes the meta-analysis 
of ASD by the Lundbeck Foundation Initiative for Integrative 
Psychiatric Research (iPSYCH) and the Psychiatric Genomics 
Consortium (PGC) released in November 2017.
The data set comprises a total of 18,381 cases and 27,969 
controls. Additional information including sample size and 
ancestry can be found in Table 1. Additional information about 
the genotyping and QC methods employed are available at the 
PGC website.
Abbreviations: ASD, autism spectrum disorder; GWAS, genome-wide association 
study; SNP, single-nucleotide polymorphism; GBA, gene-based analysis; LD, linkage 
disequilibrium; PASCAL, Pathway scoring algorithm; KEGG, Kyoto Encyclopedia of 
Genes and Genomes; GO, gene ontology; DEA, differential expression analysis; GTEx, 
genotype-tissue expression; NDD, neurodevelopmental disorder; CNV, copy number 
variation; PGC, psychiatric genomic consortium; VEGAS, versatile gene-based 
association study; iPSYCH, Lundbeck Foundation Initiative for Integrative Psychiatric 
Research; QC, quality control; OR, odd ratio; PIN, protein interaction; MEX, Mrna 
co-expression; PEX, protein co-expression; GIN, genetic interaction profile similarity; 
TFB, shared transcription factor binding; MIR, co-miRNA regulation by shared 
miRNA targeting; SCL, subcellular co-localization; DOM, domain interactions; 
PHP, phylogenetic profile similarity; QMS, quantitative mass spectrometry; FDR, 
false discovery rate; FUMA, functional mapping and annotation of genome-wide 
association studies; DEG, differentially expressed genes; TPM, transcripts per million; 
RPKM, read per kilobase per million; MTAG, multi-trait analysis of GWAS.
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Gene-Based-Analysis
PASCAL scoring algorithm (https://www2.unil.ch/cbg/index.
php?title=Pascal) was applied to the summary statistics from 
ASD meta-analysis. Individual SNPs from GWAS results were 
first mapped to genes employing a default ±50 kb window around 
5′ and 3′UTRs. The default maximum number of SNPs per gene 
allowed by PASCAL was 3,000. LD information was retrieved 
from 1000 Genomes European panel. Bonferroni correction sets 
the significance cutoff at 2.26 × 10−6 (0.05/22135 genes).
Regional Plots
LocusZoom tool (http://locuszoom.org/) was employed to construct 
regional plots for the regions containing PASCAL associated genes. 
To this aim, meta-analysis data including marker name, p-values, 
odds ratio (OR), chromosome position (start-end), and index SNP 
were specified for the analysis. The source of LD information used 
to construct the r2 correlation matrix between SNPs in these regional 
plots was retrieved from hg19/1000 Genomes Nov 2014 EUR 
(European). The rest of the optional controls were used as default.
Gene-Network Analysis
FunCoup v.4.0 (http://funcoup.sbc.su.se/search/) was employed 
to expand the list of associated genes (p < 2.26 × 10−6) including 
its interactors. FunCoup database integrates 10 different types of 
functional couplings among genes that allow to infer functional 
association networks: protein interaction (PIN), mRNA 
co-expression (MEX), protein co-expression (PEX), genetic 
interaction profile similarity (GIN), shared transcription factor 
binding (TFB), co-miRNA regulation by shared miRNA targeting 
(MIR), subcellular co-localization (SCL), domain interactions 
(DOM), phylogenetic profile similarity (PHP), and quantitative 
mass spectrometry (QMS). Gene networks for ASD were 
constructed considering as input six of the eight associated loci due 
to the lack of information for the remaining two (Table 2). Gene 
networks were constructed considering three different parameters. 
Therefore, expansion parameters include confidence threshold 
(0.8), a maximum number of 30 nodes per expansion step, and 
a query depth of 1 (only genes directly linked to the query genes 
are shown). Network expansion algorithm was settled in order 
to obtain those strongest interactors for any query gene, without 
prioritizing common neighbor’s links. Moreover, enriched term 
analyses (KEGG, GO biological function, and GO molecular 
function) were considered for each gene network constructed with 
the corresponding p-values. Gene-network representation displays 
the most significant KEGG pathways according to their q-values 
after considering a FDR approach. Node sizes scales to emphasize 
gene importance in the whole network while participating nodes 
for each KEGG pathway are marked in black.
TABLE 1 | Characterization of ASD cohorts included in PGC GWAS meta-analyses.






iPSYCH Case/control 13076/22664 European ICD10 criteria 18381/27969
PGC UCLA Autism Center of Excellence 
(ACE)
Trio 391/391 European ADI-R and/or 
ADOS
 Autism Genome Proyect (AGP) Trio 2272/2272 European ADI-R and ADOS
Autism Genetic Resource Exchange 
(AGRE)
Trio 974/974 European ADI-R and ADOS
NIMH Repository, the Montreal/
Boston Collection (MOMBOS)




Simons Simplex Collection (SSC) Trio 2231/2231 European ADI-R and ADOS
ICD10, International Classification of Diseases, 10th revision; ADI-R, Autism Diagnostic Interview—Revised; ADOS, Autism Diagnostic Observation Schedule.
TABLE 2 | FunCoup interactors detected using PASCAL associated genes as input. Some PASCAL- associated genes have not been detected by FunCoup (bold 
font). Those genes for which one or several interactors were found are shown in the table. Last column indicates the type of functional coupling among genes used to 
construct the network. Moreover, some PASCAL- associated genes and interactors were not detected by FUMA (underlined genes).






Complex and PPI 
NKX2-4 NKX2-2  OLIG2 PPI
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Functional Annotation
GENE2FUNC, a core process of FUMA (Functional Mapping 
and Annotation of Genome-Wide Association Studies) (http://
fuma.ctglab.nl/), was used to functionally annotate ASD genes 
and its interactors. Therefore, ASD input for FUMA comprises 
36 genes (PASCAL associated genes plus strong interactors from 
FunCoup) (Table 2).
Different analyses performed by GENE2FUNC were employed, 
including a gene expression heatmap and an enrichment analysis of 
differentially expressed genes (DEG). Gene expression heatmap was 
constructed employing GTEx v7 (53 tissue types) and BrainSpan 
RNA-seq data. The average of normalized expression per label 
(zero means across samples) was displayed on the corresponding 
heatmaps. Expression values are TPM (Transcripts Per Million) for 
GTEx v7 and RPKM (Read Per Kilobase per Million) in the case 
of BrainSpan data set. Heatmaps display normalized expression 
value (zero mean normalization of log2 transformed expression), 
and darker red means higher relative expression of that gene in 
each label, compared to a darker blue color in the same label. DEG 
analysis was carried out creating differentially expressed genes for 
each expression data set. In order to define DEG sets, two-sided 
Student’s t-test were performed per gene per tissue against the 
remaining labels (tissue types or developmental stages). Those 
genes with a p-value < 0.05 after Bonferroni correction and a log 
fold change ≥ 0.58 are defined as DEG. The direction of expression 
was considered. The -log10 (p-value) refers to the probability of 
the hypergeometric test.
Meta-Analysis of Differentially Expressed 
Genes in ASD Studies
dbMDEGA (https://dbmdega.shinyapps.io/dbMDEGA/) allows 
to conduct a meta-analysis using different ASD and brain 
control expression datasets to test which genes are differentially 
expressed (DEGs) between both groups. Specifically, this tool uses 
expression profiles from three human ASD brain gene expression 
datasets: GSE28475 (Chow et al., 2012), GSE28521 (Voineagu et al., 
2011), and GSE38322 (Ginsberg et al., 2012). Thus, dbMDEGA 
contains about 17,741 human genes as meta-results for querying 
DEGs. PASCAL genes and FunCoup interactors (N = 36) were 
submitted in the Meta_summary panel. Meta-analysis p-values 
(random effects model), FDR (false discovery rate) for each gene, 
and heterogeneity measures (I2) were obtained.
RESULTS
Gene-Based-Analysis
PASCAL analysis has revealed association of eight loci (p-value < 
2.26 × 10−6) (Table 3). NKX2-2 and NKX2-4 (chromosome 20) 
were highlighted as associated by PASCAL in comparison with 
the results obtained by MAGMA (Table 4). Regional association 
plot around rs910805 shows three different r2 levels. PASCAL 
is able to detect NKX2-2 and NKX2-4 as associated, both genes 
located farther away from the lead SNP. However, SNPs within 
both loci are in moderate LD with the index SNP (Figure 1). In 
addition, PASCAL shows association of CRHR1-IT1, LOC644172 
(chromosome 17), and C8orf74 (chromosome 8) (Table 3 and 
Figure 1). It is worth to note that CRHR1-IT1 is intronic with 
CRHR1 (previously reported by MAGMA) (Table 4). However, 
the vast majority of loci associated by PASCAL were previously 
reported by MAGMA (Table 4). 
Gene-Network Analysis
FunCoup has detected several interactors for PASCAL associated 
loci (Table 2). Gene network for ASD genes was constructed after 
TABLE 3 | Top 20 results reported by PASCAL for ASD GWAS meta-analysis data. Genes represented in bold surpass Bonferroni threshold (p-value < 2.26 × 10−6). 
Columns show gene, chromosome, start and end positions for each gene, the number of SNPs included in the analysis for each gene, and their PASCAL p-values.
Gene Chromosome Start position End position Number of SNPs PASCAL p-value
XRN2 chr20 21283941 21370463 271 3.53 × 10−9
NKX2-4 chr20 21376004 21378047 143 9.51 × 10−9
PLK1S1 chr20 21106623 21227258 287 4.69 × 10−8
KCNN2 chr5 113698015 113832197 540 3.89 × 10−7
NKX2-2 chr20 21491659 21494664 166 7.78 × 10−7
CRHR1-IT1 chr17 43716340 43723595 26 1.69 × 10−6
C8orf74 chr8 10530146 10558103 314 1.78 × 10−6
LOC644172 chr17 43677490 43679748 24 2.15 × 10−6
LRRC37A chr17 44372496 44415160 48 2.64 × 10−6
ARL17A chr17 44363861 44657088 64 2.82 × 10−6
KANSL1-AS1 chr17 44270938 44274089 46 2.84 × 10−6
KANSL1 chr17 44107281 44302740 153 3.07 × 10−6
MAPT-IT1 chr17 43973148 43976164 50 3.68 × 10−6
SOX7 chr8 10581277 10697299 752 4.84 × 10−6
MAPT chr17 43971747 44105699 100 4.86 × 10−6
CRHR1 chr17 43697709 43913194 275 5.45 × 10−6
MAPT-AS1 chr17 43920721 43972879 224 6.14 × 10−6
STH chr17 44076615 44077060 37 6.27 × 10−6
SPPL2C chr17 43922255 43924438 193 6.57 × 10−6
PINX1 chr8 10622883 10697299 684 7.78 × 10−6
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TABLE 4 | Significant genes reported by PASCAL and MAGMA algorithms. All significant genes reported in our study and Grove et al. publication are shown. Columns 
show chromosome, start and end positions for each gene, p-value reported by PASCAL or MAGMA, and the corresponding tag SNP for each gene.
Gene Chromosome Start position End position PASCAL/MAGMA p-value Tag SNP
Results from PASCAL gene based analysis
XRN2 20 21283941 21370463 3.53 × 10−9 rs 910805
NKX2-4 20 21376004 21378047 9.51 × 10−9 rs 910805
PLK1S1 20 21106623 21227258 4.69 × 10−8 rs 910805
KCNN2 5 113698015 113832197 3.89 × 10−7 rs 13188074
NKX2-2 20 21491659 21494664 7.78 × 10−7 rs 910805
CRHR1-IT1 17 43716340 43723595 1.69 × 10−6 rs 142920272
C8orf74 8 10530146 10558103 1.78 × 10−6 rs 10099100
LOC644172 17 43677490 43679748 2.15 × 10−6 rs 142920272
Results from MAGMA gene based analysis (Grove et al, 2019)
XRN2 20 21283942 21370463 9.69 × 10−10 rs 910805
KCNN2 5 113698016 113832197 1.02 × 10−9 rs 13188074
PLK1S1 20 21106624 21227260 5.17 × 10−9 rs 910805
MACROD2 20 13976146 16033842 1.40 × 10−7 rs 71190156
WNT3 17 44841686 44896082 4.03 × 10−7 rs 142920272
MAPT 17 43971748 44105700 5.01 × 10−7 rs 142920272
MFHAS1 8 8641999 8751131 5.58 × 10−7 rs 11249905
XKR6 8 10753654 11058875 8.01 × 10−7 rs 10099100
MSRA 8 9911830 10286401 9.15 × 10−6 rs 10099100
CRHR1 17 43697710 43913194 1.07 × 10−6 rs 142920272
SOX7 8 10581278 10588022 1.24 × 10−6 rs 10099100
NTM 11 131240371 132206716 1.32 × 10−6 rs 549507
MMP12 11 102733464 102745764 2.28 × 10−6 rs 102751102
BLK 8 11351521 11422108 2.45 × 10−6 rs 2736342
FIGURE 1 | Regional association plots for ASD GWAS meta-analysis (chromosomes 20, 8 and 7). PASCAL has highlighted associations at a gene level for NKX2-2 
and NKX2-4 (chr20), CRHR1-IT1, LOC644172 (chr17), and C8orf74 (chr8) among other genes previously associated by MAGMA.
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including 36 genes (30 subnetwork genes plus 6 query genes) and 
considering 120 links between them (Table 2). FunCoup was 
not able to detect interactors for the remaining ASD-associated 
loci. Enrichment analysis for KEGG and GO terms has shown 
association of different biological processes as spliceosome (q-value 
= 3 × 10−4), RNA transport (q-value = 2.8 × 10−3), and nucleic acid 
binding (q-value = 1.09 × 10−14) (Table 5 and Figure 2).
Functional Annotation
Gene Expression Heatmaps and Differential 
Expression Analysis
Gene expression heatmap based on GTEX v7 RNA-seq data 
for ASD-associated genes together with FunCoup interactors 
(Table 2) has revealed interesting results. Specifically, three 
genes (NKX2-2, OLIG-2, and KCNN2) display increased 
expression levels in brain (different regions) in comparison 
with the remaining tissues included in the analysis. Moreover, 
another gene set, XRN2 plus some interactors, display the 
opposite trend showing lower relative expression levels 
on brain tissues (Figure 3). Interestingly, gene expression 
heatmap employing BrainSpan data has revealed that the 
vast majority of genes included on the downregulated gene-
set have shown a higher relative expression in prenatal stages 
(early, early-mid, and late-mid). Moreover, the same trend 
was also observed for NKX2-2 and OLIG2. Therefore, a lower 
relative expression level for these genes was shown across 
prenatal stages in comparison with those levels found in adult 
brain tissues (Figure 3). Thus, there is a clear division in terms 
of expression levels for those sets of genes expressed across 
TABLE 5 | Enriched terms for query ASD genes and its interactors (subnetwork genes) according to FunCoup.
Enriched terms Genes q value
KEGG metabolic Spliceosome DH15, HNRNPK, ACIN1, ALYREF, SNW1 3 × 10−4
RNA transport SUMO2, ACIN1, ALYREF, UPF1 2.8 × 10−3
GO molecular 
function
Nucleic acid binding DDX21, ILF2, CDKN2AIP, EXOSC8, NOC3L, ACIN1, ILF3, GNL3, KNRNPF, ADAR, LYAR, SNW1, 
HNRNPK, HNRNPH1,PARN, SUMO2, DHX15, NOP2, UPF1,ALYREF, RBM39, SYNCRIP, PTBP1,








Organic cyclid compound 
binding
DDX21, ILF2, CDKN2AIP, EXOSC8, NOC3L, ACIN1, ILF3, GNL3, KNRNPF, ADAR, LYAR, SNW1, 
HNRNPK, HNRNPH1, PARN, SUMO2, DHX15, NOP2, UPF1, ALYREF, RBM39, SYNCRIP, PTBP1,
C14orf166,NONO, HNRNPUL1, XRN2, NKX2-4, NKX2-2
3.88 × 10−10
Protein binding DDX21, ILF2, CDKN2AIP, EXOSC8, ACIN1, ILF3, GNL3, KNRNPF, ADAR, LYAR, SNW1, HNRNPK, 
HNRNPH1, PARN, SUMO2, DHX15, NOP2, UPF1, ALYREF, RBM39, SYNCRIP, PTBP1,C14orf166, 
NONO, HNRNPUL1, XRN2, KCNN2, NKX2-2, KIZ, C8orf74
9.94 × 10−4
Binding DDX21,ILF2,CDKN2AIP, EXOSC8, ACIN1,ILF3,GNL3, KNRNPF,ADAR,LYAR, SNW1,HNRNPK, 
HNRNPH1,PARN,SUMO2, DHX15,NOP2, UPF1, ALYREF, RBM39, SYNCRIP, 
PTBP1,C14orf166,NONO, HNRNPUL1, XRN2,KCNN2, NKX2-2,KIZ, C8orf74, NKX2-4, NOC3L
2.81 × 10−2
Chromatin binding NKX2-2, NONO, NOC3L, UPF1, 1.03 × 10−1
Transcription factor 
binding
NKX2-2, HNRNPF, SUMO2, SNW1 1.03 × 10−1
Enzyme binding KIZ, SUMO2,C14orf166, PARN, ACIN1, HNRN,UL1, SNW1 2.54 × 10−1
Hydrolase activity, acting 
on acid anhydrides
DHX15, DDX21,ACIN1,UPF1 3.34 × 10−1
Identical protein binding KCNN2, NONO, EXOSC8, C14orf166,OLIG2 4.21 × 10−1
hydrolase activity XRN2, DHX15,ADAR, DDX21,PARN,ACIN1,UPF1 6.03 × 10−1
FIGURE 2 | ASD gene networks constructed with PASCAL associated genes and its FunCoup interactors. Node sizes scale to emphasize gene importance in the 
whole network, while participating nodes for each KEGG pathway are marked in black: (A) cAMP signaling pathway; (B) RNA transport.
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different pcw (post-conception weeks) versus those expressed 
across the adult lifespan. DEG analysis with GTEx data (adult 
brain) has shown significantly enriched DEG sets across 
distinct brain tissues. Moreover, DEG study performed with 
BrainSpan data has confirmed a significant association of gene 
sets during early prenatal stages (up-regulation) versus young 
adulthood (down-regulation). Specifically, up-regulation 
occurs around 8, 9, and 13 pcw, and down-regulation takes 
place across different postnatal ages (Figure 4).
Meta-Analysis of Differentially Expressed 
Genes in ASD Studies
Expression meta-analysis for PASCAL associated genes has 
shown differentially expressed genes between ASD brain 
individuals and controls (XRN2, p-value = 0.02; KCNN2, p-value = 
0.01;  C8orf74;  p-value = 0.03). Moreover, some of the XRN2 
interactors have also shown significant p-values when dbDMEGA 
analysis was performed (XRN2, CDKN2AIP, ILF3, GNL3 ADAR, 
LYAR, SNW1, RBM39, SYNCRIP, and PTBP1) (Table 6).
DISCUSSION
The latest ASD GWAS meta-analysis has reported the association 
of individual SNPs across chromosome 20 (rs910805), 5 
(rs13188074), 17 (rs142920272), and 8 (rs10099100), among 
others. In the same study, different genes located near to the top-
ranked SNPs as XRN2, KCNN2, and KIZ (or PLK1S1) have been 
associated by MAGMA (Grove et al., 2019). PASCAL analysis 
has shown additional associated genes: NKX2-4, NKX2-2, 
CRHR1-IT1, C8orf74, and LOC644172. However, these findings 
should not be considered as completely new. Thus, it is worth 
noting that lead SNPs located on chromosome 20 and 8 were 
FIGURE 3 | ASD gene expression heatmaps constructed with GTEX v7 (53 tissues) (left) and BrainSpan 29 different ages of brain samples data (right). Genes and 
tissues are ordered by clusters for the GTEX heatmap. In the case of BrainSpan heatmap, genes are ordered by expression clusters, and neurodevelopmental 
stages are chronologically classified from prenatal to postnatal stages.
FIGURE 4 | ASD DEG plots constructed with GTEX v7 (53 tissues) (left) and BrainSpan 29 different ages of brain samples data (right). Significantly enriched DEG 
sets (Pbon < 0.05) are highlighted in red.
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associated with ASD when MTAG (multi-trait analysis of GWAS) 
was done with genetically correlated phenotypes (schizophrenia 
and educational attainment) but not by MAGMA itself (Turley 
et al., 2018; Grove et al., 2019). In fact, this is why NKX2-4 and 
NKX2-2 were reported as “possibly associated” genes when 
MTAG was carried out (Grove et al., 2019). However, we found 
that PASCAL is able to rescue these associations when its own 
statistical approach is applied. It is also worth to note that 
CRHR1-IT1 partially overlap with CRHR1 even if it encodes 
a different transcript (previously not reported by MAGMA). 
Thus, CHR1-IT1 is reported as associated by PASCAL due to the 
inclusion of the “gene-name” in the list used as input (present 
in PASCAL and not in MAGMA). c8orf74 could also be a 
controversial “new” finding because the SNPs located within 
the gene harbor more significant p-values but are located near 
to XKR6 (identified in Grove et al, 2019). Even so, it should be 
considered that PASCAL has helped to unveil the association of 
additional genes near to those genes reported by MAGMA. Both 
GBA tools, MAGMA and PASCAL, work in a very similar way: 
i) they are able to employ summary statistics as input instead of 
genotypes, ii) gene scores are calculated combining the results 
for all SNPs located across the gene, and iii) LD correction 
is made by external information from the 1000 Genomes 
European panel (de Leeuw et al., 2015; Lamparter et al., 2016). 
However, the construction of the correlation matrix is slightly 
different between both methods. This could explain those small 
differences found between the associated genes reported by 
both methods. p-values associated to each gene in PASCAL 
were in general less significant than those reported by MAGMA, 
even when identical genes were reported by both algorithms. 
Moreover, the number of genes that remain significant after 
Bonferroni correction was lower in PASCAL. All these results 
taken together could indicate that PASCAL is more conservative 
than MAGMA. In addition, we propose that PASCAL could be 
used as a complementary GBA approach because it has helped 
to highlight additional genes located in the same LD region than 
those reported by MAGMA.
Regarding the insight into the biological role of ASD-associated 
genes, we would like to focus on the following loci: NKX2-2, 
NKX2-4, CRHR1-IT1, LOC644172, and c8orf74. NKX2-2 and 
TABLE 6 | PASCAL associated genes and interactors. p-values from PASCAL and dbMDEGA meta-analysis are shown for each gene. p-values from dbMDEGA were 
computed using the p-value method. Heterogeneity values (I2) are also shown. (NA = the gene is not in dbMDEGA).
Gene p-val PASCAL p-val dbMDEGA FDR dbMDEGA Heterogeneity
XRN2 3.52863316 × 10−9 0.02 0.12 0%
NKX2-4 9.5086814 × 10−9 NA NA NA
PLK1S1 4.68346333 × 10−8 NA NA NA
KCNN2 3.88782618 × 10−7 0.01 0.11 0%
NKX2-2 7.7773789 × 10−7 0.23 0.37 0%
CRHR1-IT1 1.6858736 × 10−6 NA NA NA
C8orf74 1.77348539 × 10−6 0.03 0.16 43%
LOC644172 2.15004243 × 10−6 NA NA NA
DDX21 8.86663103 × 10−1 0.3 0.41 69%
ILF2 5.52756293 × 10−1 0.38 0.45 28%
CDKN2AIP 8.21802658 × 10−1 0.04 0.17 0%
EXOSC8 9.41352461 × 10−2 0.1 0.26 64%
NOC3L 3.66793335 × 10−1 0.35 0.44 0%
ACIN1 9.65129025 × 10−1 0.15 0.3 48%
ILF3 1.0116456 × 10−1 0.01 0.1 66%
GNL3 2.39022069 × 10−3 0.01 0.07 67%
KNRNPF NA NA NA NA
ADAR 1.70702835 × 10−2 0.01 0.1 72%
LYAR 2.30069599 × 10−1 0.03 0.15 0%
SNW1 1.0892706 × 10−1 0.04 0.18 74%
HNRNPK 3.13685174 × 10−1 NA NA NA
HNRNPH1 6.07006486 × 10−1 NA NA NA
PARN 9.01671731 × 10−1 0 0.03 79%
SUMO2 8.85347296 × 10−1 0.27 0.39 72%
DHX15 2.93250866 × 10−1 0.12 0.38 0%
NOP2 7.85747107 × 10−1 NA NA NA
UPF1 2.08668839 × 10−1 0.12 0.27 14%
ALYREF 2.00036414 × 10−1 NA NA NA
RBM39 2.90163509 × 10−1 0.06 0.2 18%
SYNCRIP 2.62087002 × 10−1 0.01 0.08 0%
PTBP1 9.27312631 × 10−2 0.02 0.13 0%
C14orf166 2.91369259 × 10−1 0.36 0.44 58%
NONO NA 0.18 0.33 32%
HNRNPUL1 4.2805356 × 10−1 NA NA NA
CALM1 3.30876236 × 10−1 0.4 0.46 27%
CALM2 9.81305815 × 10−1 0.36 0.44 0%
CALM3 7.91761032 × 10−1 0.5 0.5 0%
OLIG2 4.52957535 × 10−1 0.4 0.46 0%
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NKX2-4 are members of the homeobox-transcription factor 
family. NKX2-2 encodes a transcription factor involved in the 
morphogenesis of the central nervous system, and it is essential 
during the differentiation of neural populations located on the 
hindbrain and spinal cord during early development (Briscoe 
and Ericson, 1999). NKX2-4 (Homeobox Protein Nkx-2.4) has 
a key role in brain development, and its downregulation in 
the developing forebrain promotes proliferation and inhibits 
differentiation of neural progenitors which results in impaired 
neurogenesis (Shen et al., 2018). Gene expression heatmaps 
(GTEX and BrainSpan data) have revealed two expression 
clusters in which NKX2-2 is involved. Genes within the first 
cluster have shown downregulation across early prenatal stages 
and upregulation during postnatal stages, and genes within the 
second cluster have shown the opposite trend. NKX2-2 and its 
interactor OLIG-2 (oligodendrocyte transcription factor 2) are 
included in the first cluster that displays a lower normalized 
expression during prenatal stages in comparison with postnatal 
stages. This seems to point to the existence of a different 
genetic regulation for NKX2-2 during brain development in 
comparison with the adult brain. Thus, it was reported that 
NKX2-2 is initially expressed in differentiating oligodendrocyte 
precursor cells (OPCs) and then is downregulated. However, it 
was demonstrated that its expression could also be upregulated 
again during later neurodevelopmental stages in order to 
maintain myelin structures (Cai et al., 2010). This is particularly 
interesting due to previous reports that have linked aberrant 
expression of genes across the oligodendrocyte lineage with 
ASD pathology (Li et al., 2014; Zeidán-Chuliá et al., 2016). In 
addition, enriched terms for NKX2-2 and OLIG-2 were protein, 
chromatin, and TF binding, all of them biological processes 
involved in ASD pathogenesis. However, it should be noted 
that both genes did not show differences in expression between 
ASD brain tissue and controls when DEG was carried out. These 
results indicate the need of subsequent functional studies to 
further characterize their biological role.
In addition, a second ASD expression cluster (BrainSpan 
heatmap) includes XRN2, CRHR1-IT1, and their multiple 
interactors. First of all, it should be remarked that FunCoup 
calculates many more interactors for XRN2 than for the 
remaining genes. This could entail a bias for subsequent analysis 
but also underlines the relevance of this gene due to its wide 
PPI network. Thus, it is worth to note that many XRN2 and 
some of its interactors (CDKN2AIP, ILF3, GNL3 ADAR, LYAR, 
SNW1, RBM39, SYNCRIP, and PTBP1) have shown significant 
p-values when dbMDEGA meta-analysis was performed. This 
fact demonstrates that these genes are differentially expressed 
between ASD brains and controls and therefore their potential 
relevance in ASD pathogenesis (Voineagu et al., 2011; Chow 
et al., 2012; Ginsberg et al., 2012). In addition, some of the 
enriched terms for XNR2 and their interactors were spliceosome, 
RNA transport, and nucleic acid binding, all of them essential 
biological functions with a role during early development. 
Thus, it was demonstrated that XRN2 might serve a general 
role in triggering the termination of transcription through the 
degradation of the 3′ UTR (Eaton et  al., 2018). CRHR1-IT1 
codifies for a long intergenic non-protein coding RNA which 
was recently associated with susceptibility to antisocial behavior 
(Day et al., 2018). CRHR1-IT1 shares part of its sequence with 
CRHR1 which encodes the corticotropin-releasing hormone 
receptor 1 (Grove et al., 2019). CRHR1 is a main component 
of the hypothalamic-pituitary-adrenal pathway, and it has 
been repeatedly associated with response to stress-related 
psychopathology (Binder and Nemeroff, 2010). The function 
of CRHR1-IT1 is not well characterized, but it might play a 
role in the regulation of CRHR1 expression. Thus, CRHR1 and 
CRHR1-IT1 could be involved in the modulation of behavior and 
cognition, both core features of ASD (Smith et al., 2016; Grimm 
et al., 2017; Day et al., 2018; Zhong et al., 2018). However, the 
meta-analysis of DEG in ASD brain vs controls has not revealed 
association for CRHR1 nor CRHR1-IT1.
Finally, C8orf74 and LOC644172 were also associated after 
PASCAL analysis. LOC644172 is located upstream of CRHR1 
and CRHR1-IT1, but it was not recognized by FunCoup nor 
FUMA. C8orf74 is part of a reading frame that has the ability to be 
translated, but it is not yet characterized. Thus, it seems that both 
loci are not included in functional and genetic databases due to 
their poor biological characterization. However, the meta-analysis 
of expression profiles revealed that C8orf74 was differentially 
expressed between ASD brain tissues and controls, which 
indicates that C8orf74 needs further functional characterization.
CONCLUSIONS
PASCAL algorithm was used to carry out a novel GBA of ASD, 
employing summary statistics from the latest GWAS meta-
analysis. This study has identified several gene associations even 
though most of them were previously reported by MAGMA. 
However, PASCAL has been useful to define the association of 
other genes located in the same LD region than those found 
by MAGMA. These results indicate that PASCAL should be 
considered as a complementary GBA approach when it is 
necessary to further mine GWAS results.
The second part of this study has been focused on the biological 
characterization of the ASD-associated genes by PASCAL. Thus, 
gene-network and functional annotation approaches including 
gene expression heatmaps and DEG were carried out. This 
has helped to understand the genetic findings into a biological 
context and to select the most suitable ASD susceptibility genes 
as candidates for functional biological studies.
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